Your browser doesn't support javascript.
loading
Posttraumatic stress disorder symptom trajectories in a 16-month COVID-19 pandemic period.
López-Castro, Teresa; Papini, Santiago; Bauer, Alexandria; Swarbrick, Margaret; Paul, Lynn K; Nizzi, Marie-Christine; Stanley, Damian; Team, Covid-Dynamic; Hien, Denise.
Afiliação
  • López-Castro T; Psychology Department, Colin Powell School of Civic and Global Leadership, The City College of New York, New York, New York, USA.
  • Papini S; Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.
  • Bauer A; Center of Alcohol & Substance Use Studies, Rutgers University, New Brunswick, New Jersey, USA.
  • Swarbrick M; Center of Alcohol & Substance Use Studies, Rutgers University, New Brunswick, New Jersey, USA.
  • Paul LK; Division of Humanities and Social Sciences, California Institute of Technology, Pasadena, California, USA.
  • Nizzi MC; Brain Institute, Chapman University, Orange, California, USA.
  • Stanley D; Division of Humanities and Social Sciences, California Institute of Technology, Pasadena, California, USA.
  • Team CD; Gordon F. Derner School of Psychology, Adelphi University, Garden City, New York, USA.
  • Hien D; Center of Alcohol & Substance Use Studies, Rutgers University, New Brunswick, New Jersey, USA.
J Trauma Stress ; 36(1): 180-192, 2023 02.
Article em En | MEDLINE | ID: mdl-36572985
ABSTRACT
COVID-19 pandemic presents an unheralded opportunity to better understand trajectories of posttraumatic stress disorder (PTSD) symptoms across a prolonged period of social disruption and stress. We tracked PTSD symptoms among trauma-exposed individuals in the United States and sought to identify population-based variability in PTSD symptom trajectories and understand what, if any, early pandemic experiences predicted membership in one trajectory versus others. As part of a longitudinal study of U.S. residents during the pandemic, participants who reported at least one potentially traumatic experience in their lifetime (N = 1,206) at Wave 1 (April 2020) were included in the current study. PTSD symptoms were assessed using the PCL-5 at four time points extending to July 2021. Latent growth mixture modeling was used to identify heterogeneous symptom trajectories. Trajectory membership was regressed on experiences from the early stage of the pandemic as measured using the Epidemic-Pandemic Impacts Inventory in a model that controlled for variables with documented associations to PTSD trajectories, including age, sex, income, and trauma history. Four trajectories were identified, categorized as resilient (73.0%), recurring (13.3%), recovering (8.3%), and chronic (5.5%). Emotional and physical health problems and positive changes associated with the early phase of the pandemic were each significant predictors of trajectory membership over and above all other variables in the model. Predictors primarily differentiated the resilient trajectory from each of the other three trajectories. Distinct PTSD symptom trajectories during the COVID-19 pandemic suggest a need for targeted efforts to help individuals at most risk for ongoing distress.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos de Estresse Pós-Traumáticos / COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transtornos de Estresse Pós-Traumáticos / COVID-19 Idioma: En Ano de publicação: 2023 Tipo de documento: Article